Sarah Cannon Research Institute — Nashville, Tennessee

Public research footprint of Sarah Cannon Research Institute, compiled from the ClinicalTrials.gov public registry.

956

Registered studies

293

Active

165

Recruiting now

441

Completed

203

Stopped or withdrawn

Most-studied conditions

Pancreatic Ductal Adenocarcinoma · Non-Small Cell Lung Cancer · Solid Tumor · Solid Tumors

Recently updated registry entries

NCT07644559 — A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer (Recruiting)
NCT06823167 — A Phase 1 Study of IM-1021 in Participants With Advanced Cancer (Recruiting)
NCT06526819 — SMP-3124LP in Adults With Advanced Solid Tumors (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Sarah Cannon Research Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.